Reviewer Policies
- Reviewers Guidelines
The International Journal of Pharmaceutical Sciences Letters (IJPSL) follows a robust peer review process to ensure the quality, relevance, and scientific validity of the articles it publishes. Reviewers play a critical role in maintaining the standards of the journal and ensuring that the content is accurate, relevant, and of high scientific value.
Key Guidelines for Reviewers:
- Confidentiality: Reviewers must treat all manuscripts as confidential. The manuscript is the intellectual property of the authors, and it must not be shared with others or discussed outside the peer review process. Reviewers should not disclose details of the manuscript, its content, or any related information during or after the review process.
- Objectivity and Impartiality: The primary responsibility of a reviewer is to assess the manuscript objectively, based solely on the scientific quality of the work. Personal biases, institutional affiliations, or any other conflicts should not influence the review. Reviewers should assess the study design, methodology, results, and conclusions, ensuring the manuscript adheres to scientific standards.
- Timeliness: Reviewers are expected to complete their reviews within a reasonable timeframe, typically within 2–4 weeks from the invitation to review. If the reviewer is unable to meet the timeline, they should inform the editor immediately, allowing the editor to assign another reviewer.
- Constructive and Detailed Feedback: Reviewers should provide constructive, actionable feedback that can help authors improve their manuscripts. Reviewers are encouraged to comment on all aspects of the paper, including the introduction, methods, results, discussion, and conclusions. Comments should be specific and clear, and when suggesting revisions, reviewers should provide clear guidance on how the manuscript could be improved.
- Ethical Standards: Reviewers must follow ethical guidelines to ensure that the review process is fair and unbiased. If a reviewer suspects misconduct such as plagiarism, data fabrication, or falsification, they should immediately report their concerns to the editor. The reviewer should also avoid reviewing a manuscript if they suspect a conflict of interest with the authors or their research.
- Recommendation: After reviewing the manuscript, the reviewer should provide a clear recommendation to the editor. The possible recommendations are typically:
- Accept: The manuscript is scientifically sound and requires no further revisions.
- Minor Revisions: The manuscript is acceptable for publication with minor corrections or clarifications.
- Major Revisions: The manuscript needs substantial changes to improve clarity, data presentation, or scientific rigor before it can be reconsidered.
- Reject: The manuscript does not meet the journal’s standards or is not within the scope of the journal.
- No Use of Information for Personal Benefit: Reviewers must not use any information, data, or ideas from the manuscript for their own personal or professional gain. This includes any potential application of the research findings in their own studies or commercial ventures.
- Recommendations for Improvements: Reviewers are encouraged to suggest additional references or studies that could strengthen the manuscript. This feedback should be offered diplomatically, respecting the authors' work while guiding them toward improving the quality of their research.
By adhering to these guidelines, reviewers help ensure that the IJPSL maintains its high standards and continues to publish valuable and scientifically rigorous research in the field of pharmaceutical sciences.
2. Conflict of Interest and Financial Disclosures (Specific to Reviewers)
To ensure transparency and impartiality in the peer review process, the International Journal of Pharmaceutical Sciences Letters (IJPSL) requires all reviewers to disclose any potential conflicts of interest (COI) before accepting a manuscript for review. This ensures that the review process is conducted in an objective and unbiased manner, which is essential for maintaining the journal’s credibility and scientific integrity.
Key Aspects of the Conflict of Interest and Financial Disclosures Policy for Reviewers:
- Definition of Conflict of Interest: A conflict of interest occurs when a reviewer has any financial, professional, or personal relationship with the authors, their institutions, or the research topic that could potentially bias their judgment during the review process. Such conflicts could arise from:
- Financial Interests: Any direct or indirect financial relationship with the authors, such as funding or sponsorship from the same pharmaceutical companies, research institutions, or related organizations.
- Personal Relationships: Close personal connections, such as family members, friends, or colleagues, that could lead to biased evaluation.
- Professional Affiliations: Collaborations or competing research with the authors that could influence the reviewer’s objectivity.
- Intellectual Biases: Strong disagreements over the scientific methods or conclusions that could affect impartial judgment.
- Disclosure of Conflicts: Before agreeing to review a manuscript, the reviewer must disclose any potential conflicts of interest to the editor. This disclosure should include:
- Financial relationships with pharmaceutical companies, research institutions, or organizations that could be perceived as biases in the review process.
- Personal or professional relationships with any of the authors.
- Any other circumstances that may lead to a perceived or actual conflict of interest.
If there is any uncertainty about the potential conflict, reviewers are encouraged to err on the side of disclosure.
- Recusal from Review Process: If a reviewer acknowledges any conflict of interest, whether financial or personal, they should recuse themselves from the review process for that particular manuscript. In such cases, the reviewer should inform the editor immediately and, if necessary, suggest an alternative reviewer who may have no conflicts with the manuscript.
- Impartial Evaluation: Reviewers are expected to provide an impartial and fair evaluation of the manuscript, regardless of any personal, financial, or professional ties to the authors or their institutions. Reviewers should assess the scientific quality of the research, including the soundness of the methodology, accuracy of results, and the overall contribution to the field, without being influenced by outside relationships.
- Handling of Conflicts During the Review Process: If a conflict of interest is identified after the review process has started, the reviewer must inform the editor immediately. In cases where the conflict of interest is found to have influenced the reviewer’s feedback or recommendation, the manuscript may be reassigned to another reviewer to ensure an unbiased evaluation.
- Non-Financial Conflicts: Conflicts of interest are not limited to financial considerations. Professional rivalry, personal disagreements, or ideological biases regarding the research area may also influence a reviewer’s judgment. Reviewers should assess whether any of these factors may unduly influence their review and recuse themselves if necessary.
- Transparency: The IJPSL encourages reviewers to be transparent in their communications and to provide honest and open feedback to the editor. If a reviewer is unsure whether a situation constitutes a conflict of interest, they should consult the editor for guidance.
- No Personal Gain: Reviewers should not use information from the manuscript under review for personal or professional gain. This includes refraining from using unpublished data or ideas from the manuscript in their own research, publications, or business ventures. Any potential conflicts of interest related to personal gain should be disclosed and avoided.
- Avoiding Bias: Reviewers should ensure that their reviews are objective and free from bias. For example, a reviewer should not reject a manuscript merely because they disagree with the methodology, research findings, or conclusions if these are well-supported by data. Similarly, a reviewer should not accept a manuscript solely because they agree with the authors’ views if the research does not meet the required scientific standards.
-
Managing Conflicts in the Peer Review Process:
- Editor’s Role in Managing Conflicts: The editor plays an important role in managing conflicts of interest. Editors must ensure that reviewers are selected based on their expertise and that they do not have any conflicts of interest that might affect their ability to review the manuscript impartially. In cases where a conflict of interest arises, editors may reassign the manuscript to another reviewer to maintain the integrity of the review process.
- Additional Measures: The IJPSL encourages reviewers to report any potential conflicts during the review process. If a conflict of interest is identified after the review, the editor may decide to assign a new reviewer or take appropriate action, such as issuing a correction or retraction in cases where the review may have been compromised.
